General Information of Drug (ID: DM3NP4I)

Drug Name
Huntingtin gene antisense Drug Info
Indication
Disease Entry ICD 11 Status REF
Huntington disease 8A01.10 Preclinical [1]
Therapeutic Class
Antisense
Cross-matching ID
TTD Drug ID
DM3NP4I

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Preclinical Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
ALN-HTT DM8T6H7 Huntington disease 8A01.10 Preclinical [3]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Huntingtin messenger RNA (HTT mRNA) TTIWZ0O HD_HUMAN Not Available [2]

References

1 Clinical pipeline report, company report or official report of Alnylam Pharmaceuticals, Inc.
2 Design and development of antisense drugs. Expert Opin. Drug Discov. 2008 3(10):1189-1207.
3 Clinical pipeline report, company report or official report of Alnylam Pharmaceuticals, Inc (2011).